XML 64 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - CAD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating activities    
Net loss from continuing operations $ (3,300,493) $ (300,740)
Adjustments for non-cash items:    
Unrealized gain on changes in fair value of biological assets (56,614) (92,503)
Changes in fair value included in inventory sold 91,825 71,821
Depreciation of property, plant and equipment 74,314 45,362
Amortization of intangible assets 40,577 42,893
Share-based compensation 59,899 107,039
Non-cash acquisition costs 0 4,243
Impairment of property, plant and equipment 157,838 0
Impairment of investment in associate 75,035 73,289
Impairment of intangible assets and goodwill 2,544,144 9,002
Accrued interest and accretion expense 18,591 22,798
Accrued interest and accretion expense (4,835) (265)
Deferred tax expense (recovery) (78,303) (23,909)
Other (losses) gains, net 28,643 (109,464)
Foreign exchange loss 12,779 (3,814)
Changes in non-cash working capital 7,643 (37,285)
Net cash used in operating activities from discontinued operations (8,995) (712)
Net cash used in operating activities (337,952) (192,245)
Investing activities    
Marketable securities and derivative investments (2,000) (50,584)
Proceeds from disposal of marketable securities and derivatives 90,843 46,975
Purchase of property, plant and equipment, and intangible assets (355,006) (414,190)
Disposal of property, plant and equipment 3,739 0
Acquisition of businesses, net of cash acquired 280 114,213
Payment of contingent consideration (1,993) (4,112)
Loan receivable (3,643) 0
Dividends received 0 828
Deposits (17,744) (5,452)
Proceeds from disposal of investment in associates 27,600 134
Net cash used in investing activities from discontinued operations 8,441 (109)
Net cash used in investing activities (249,483) (312,297)
Financing activities    
Proceeds from long-term loans 86,394 605,104
Repayment of long-term loans (115,130) (21,126)
Repayment of short-term loans 0 (238)
Repayment of convertible debenture (2,306) 0
Payments of principal portion of lease liabilities (7,788) 0
Proceeds from lease inducements 1,746 0
Restricted cash 46,066 (32,668)
Financing fees (1,789) (18,709)
Shares issued for cash, net of share issue costs 575,506 59,331
Capital contribution from non-controlling interest 0 5,854
Net cash used in financing activities from discontinued operations (137) 0
Net cash provided by financing activities 582,562 597,548
Effect of foreign exchange on cash and cash equivalents (5,675) 2,936
Increase (decrease) in cash and cash equivalents (10,548) 95,942
Cash and cash equivalents, beginning of year 172,727 76,785
Cash and cash equivalents, end of year $ 162,179 $ 172,727